Where wellness begins with passion.

The Management Team

A wide range of knowledge, experience and know-how.
Avidas Pharmaceuticals' entrepreneurial management team has a proven track record in building and growing profitable specialty pharmaceutical portfolios and has extensive operational, sales, marketing and financial experience in the global pharmaceutical industry.

Margie Gardner
Founder, President & Chief Executive Officer
Margie most recently served as Senior Vice President, King Pharmaceuticals where she was responsible for significant growth in profits and advancing the portfolio pipeline. She has over twenty-five years US and international pharmaceutical experience. Previously, Margie was Worldwide Executive Director for Merck. Before joining Merck, she was Executive Director for GlaxoSmithKline. She began her career at SmithKline and held various global and US Leadership positions in Sales, Marketing, Strategy Development, General Administration and Finance. Margie holds a Bachelor of Science Degree in Business Administration from Drexel University.

Dan McCall
Co-Founder, Chief Operating Officer
Dan most recently served as Senior Vice President King Pharmaceuticals, Sales and Operations. He has over twenty years of pharmaceutical experience with expertise in Sales and Marketing, Sales Force sizing and structure, Managed Markets, and Alliance Management. Dan has led small and large Specialty Commercial Operations. He launched four specialty sales forces and built the supporting organizations. Prior to 1997, he held various positions at Glaxo Pharmaceuticals and The Upjohn Company. Dan has a Bachelor of Science in Biology from Milligan College and an MBA from Wake Forest University.

Michael Worne, FCA
Vice President Business Development
Michael most recently served as President, MW Consulting. He is a Chartered Accountant with over 17 years of global pharmaceutical experience. He held various leadership positions at SmithKline Beecham as Pharmaceutical Sector Planner Organizational Redesign, Director Strategic Product Development. He began his career at Robson Rhodes in London and later with Peat Marwick Mitchell. He has a demonstrated track record in acquisitions and disposals with international experience in Finance, Business Development, Strategic Product Development, Organizational Redesign and Marketing. Michael is a qualified member of the Institute of Chartered Accountants in England & Wales.

Management Overview

Margie Gardner

Chief Executive Officer

Dan McCall

Chief Operating Officer

Michael Worne, FCA

VP Business Development

Scientific Advisors

Dr. Charles Pamplin, MD
Dr. Mitchel P. Goldman, MD
Dr. Zoe Diana Draelos, MD
Dr. Guy F. Webster MD, PhD